IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET). - Nochi Z; Pia H; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Fardo F; Genser B; Goetz M; Kostenko AV; Leone C; Li T; et al. (Trials, 2022)